Peripheral Neuropathic Pain Clinical Trial
Official title:
A Phase 2a, Randomized, Double-blind, Placebo-controlled Crossover Study to Explore the Effects of ACD440 in Patients With Peripheral Neuropathic Pain With Sensory Hypersensitivity.
This is a double-blind, randomized, placebo-controlled crossover outpatient study in patients with peripheral neuropathic pain with allodynia or hyperalgesia to cold, heat, brush and/ or pinprick stimulation. Patients will in random order receive ACD440 Gel or placebo treatment twice daily for 7 days, topically applied to the painful area. This is followed by a 2-week washout period, then receive the alternate treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03733886 -
Burst Spinal Cord Stimulation for Neuropathic Pain.
|
N/A | |
| Completed |
NCT04494815 -
A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04431778 -
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT03191136 -
Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02100046 -
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
|
Phase 2 | |
| Completed |
NCT06234917 -
Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning
|
N/A | |
| Completed |
NCT03009500 -
Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain
|
Phase 3 | |
| Completed |
NCT01524796 -
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
|
||
| Completed |
NCT02985216 -
Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain
|
Phase 3 | |
| Recruiting |
NCT04171453 -
Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
|
||
| Completed |
NCT01737294 -
Observation of the Use of QUTENZA™ in Standard Clinical Practice
|
N/A | |
| Active, not recruiting |
NCT05890053 -
To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia
|
Phase 3 | |
| Completed |
NCT05219812 -
A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain
|
Phase 2 | |
| Terminated |
NCT01293851 -
Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
|
||
| Completed |
NCT02209896 -
BlueWind Reprieve System for the Treatment of PNP
|
N/A | |
| Completed |
NCT01240148 -
Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT05817591 -
Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort
|